[ad_1]
On Wednesday, the Department of Health and Human Services announced that it would end the use of human fetal tissue derived from voluntary abortions for medical research. This is yet another victory for the Trump administration in the endless battle to protect human life.
For over 25 years, the Congress has allowed the National Institutes of Health to distribute more than $ 100 million a year to researchers who use the fetal tissue of aborted babies. There is little to show for this money. As a panel of investigators selected by the Chamber found, fetal tissue research has not delivered any promise of major scientific discovery. As Sean Duffy and Kathleen Schmainda write in The Federalist, "The panel survey further discredits the claim that fetal tissue plays an indispensable role in research that" saves life " .
Lobbyists in favor of abortion falsely claim that there is no alternative to fetal tissue obtained from voluntary abortions. Yet, as Tara Lee Sander told Congress in December, "after more than 100 years of research, no treatment requiring aborted fetal tissue has been developed." In fact, only three of the 75 vaccines available in America still use the inherited fetal cell lines and none of them require the use of new fetal samples.
In the field of neuroscience, the use of fetal tissue grafts to replace defective dopaminergic neurons in patients with Parkinson's disease is generating enthusiasm, but Sander Lee points out that induced pluripotent stem cells (a type of derived cell adult tissue) promising alternative. Last fall, researchers in Japan transplanted for the first time pluripotent stem cells induced in a Parkinson's patient. In addition, NIH announced a $ 20 million contribution to research on fetal tissue alternatives.
If the Trump administration continues to inject taxpayer money into fetal tissue research while ignoring viable alternatives, the demand for the body parts of aborted babies would only increase.
We have already seen greedy entrepreneurs watching the fetal tissue market. In 2010, Cate Dyer, an employee of a nonprofit fetal tissue processing company, created her own for-profit company called StemExpress. Her former bosses described her as "totally unethical", recalling that she "went into our office one evening, looked around us, took everything we had and started his own business ".
Dyer's company was largely featured in a secret video video that appeared in 2015. In response to a video of herself laughing about the transportation of cut fetal heads to the labs, she said that his "tiny" trade in fetal tissue cost him real money. She later refused to cooperate with Congressional investigators, who provided evidence that her company of 37 employees aggressively advocated her fetus need at abortion clinics, promising that the "fetus" would not be allowed. operation would be "financially profitable" for all concerned.
From 2010 to 2014, StemExpress revenues increased from $ 156,312 to $ 4.5 million (see page 155).
It is not difficult to see the temptation of profiteers. Abortion clinics sell deceased babies to fetus processors for only US $ 30, while treatment companies sell each "component" of the baby to researchers for US $ 550.
Clinics will also benefit from the growing demand for aborted babies, but their marketing strategies are less obvious: discount procedures, promise of future medical care – all targeted at poor women and minorities. According to Scott Rae, professor of ethics at Biola University, such methods are "difficult to detect and impossible to control."
Finally, the acceptance of fetal tissue as a research tool or "miracle cure" undermines the longstanding protections of the Hyde Amendment, which prevent taxpayers from being forced to financially support an industry that many find it odious.
The importance of the Hyde amendment, which Democrats have promised to repeal, can not be overstated. Prior to the Supreme Court ruling in favor of the amendment, about 300,000 pregnancies had been closed each year thanks to taxpayers' money – a situation that can never be repeated.
It is clear that because of the availability of fetal tissue substitutes and the fragility of our current protections against taxpayer funding for abortions, the current government has issued a just and moral appeal today and has decided to protect the child of our country.
Mary Vought (@ MaryVought) is a contributor to Washington Examiner's Beltway Confidential blog. She is a Republican strategist and executive director of the Senate Conservatives Fund. Previously, she was press secretary for the House Republican Conference, chaired at the time by President Mike Pence.
[ad_2]
Source link